Literature DB >> 16209159

Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab.

Justin Vujevich1, Matthew Zirwas.   

Abstract

We describe an 18-year-old man with a 7-year history of severe major aphthous stomatitis refractory to multiple standard therapies who responded completely to therapy with adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor alpha (TNF-alpha).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16209159

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


  8 in total

1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 3.  Biological agents: what they are, how they affect oral health and how they can modulate oral healthcare.

Authors:  E Georgakopoulou; C Scully
Journal:  Br Dent J       Date:  2015-07       Impact factor: 1.626

Review 4.  Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check.

Authors:  Shesha Prasad Ranganath; Anuradha Pai
Journal:  J Clin Diagn Res       Date:  2016-10-01

5.  Regression of major recurrent aphthous ulcerations using a combination of intralesional corticosteroids and levamisole: a case report.

Authors:  Bruna Lavinas Sayed Picciani; Geraldo Oliveira Silva-Junior; Davi Silva Barbirato; Ruth Tramontani Ramos; Marilia Heffer Cantisano
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 6.  Adalimumab in dermatology.

Authors:  Pawel Traczewski; Lidia Rudnicka
Journal:  Br J Clin Pharmacol       Date:  2008-07-11       Impact factor: 4.335

Review 7.  Informed consent and biological agents in rheumatology and internal medicine.

Authors:  Gabriele Mandarelli; Florenzo Iannone; Stefano Ferracuti; Ignazio Grattagliano; Marcello Benevento; Biagio Solarino; Davide Ferorelli; Roberto Catanesi
Journal:  Eur J Clin Invest       Date:  2022-05-18       Impact factor: 5.722

8.  Combination of Levamisole with Prednisone in Treating Recurrent Major Aphthous Ulcer in a Young Boy: A Case Report.

Authors:  Jyoti Prajapat; Rajesh Prajapat; Sanjeev B Khanagar; Satish Vishwanathaiah; Sachin Naik; Chitra Jhugroo; Darshan Devang Divakar
Journal:  Clin Pract       Date:  2021-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.